Results

Total Results: 2,228 records

Showing results for "disease".

301. Hypertension-Pulmonary-Arterial Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypertension-pulmonary-arterial_executive.pdf
     April 01, 2013 - 1.4.2 HIV infection 1.4.3 Portal hypertension 1.4.4 Congenital heart diseases … dysfunction 2.3 Valvular disease 3. … Pulmonary hypertension owing to lung diseases and/or hypoxemia 3.1 Chronic obstructive pulmonary … disease 3.2 Interstitial lung disease 3.3 Other pulmonary diseases with mixed restrictive … , or chronic obstructive pulmonary disease.

302. S158 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s158.pdf
     October 01, 2007 - Availability of information on disease outcome will affect choice of analytic strategies. … limitations when they are used to assess the role of medications in the etiology and management of chronic diseases … not have been completely controlled for in observational studies on pharmacopreven- tion of chronic diseases … These databases are, however, often the best source of information on the association between drugs and diseases … The treatment of unrelated disor- ders in patients with chronic medical diseases.

303. RESPONSE TO REQUEST FOR WORK ASSIGNMENT (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/copd-anticholinergic-medicines_research.pdf
     December 01, 2009 - for markers of disease severity differences may remain between groups. … A 4- year trial of tiotropium in chronic obstructive pulmonary disease. … A 4- year trial of tiotropium in chronic obstructive pulmonary disease. … Tiotropium for stable chronic obstructive pulmonary disease: A meta- analysis. … A 4- year trial of tiotropium in chronic obstructive pulmonary disease.

304. Bladder-Cancer-Non-Muscle-Invasive Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/bladder-cancer-non-muscle-invasive_research-protocol.pdf
     July 21, 2014 - such as age, sex, ethnicity, performance status, or medical comorbidities such as chronic kidney disease … We will exclude studies of biomarkers for prediction of treatment response or disease progression. … While identification of biomarkers for predicting treatment response and disease progression are important … Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer … heading word, keyword heading word, protocol supplementary concept word, rare disease

305. Microsoft Word - finapps.doc (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_appendixes-2007.pdf
     January 01, 2007 - Atherosclerotic renovascular disease in United States patients aged 67 years or older: risk factors … Progression of atherosclerotic renovascular disease: A prospective population-based study. … Atherosclerotic renovascular disease: medical therapy versus medical therapy plus renal artery stenting … stage 3A, baseline GFR 41-59 mL/min 2 Chronic kidney disease stage 3A, baseline GFR 30-40 mL/min 3 … ARAS, atherosclerotic renal artery stenosis; CKD, chronic kidney disease; CVD, cardiovascular disease

306. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0278_03-10-2008.pdf
     January 01, 2008 - 09 1 Results of Topic Selection Process & Next Steps  Clostridium difficile-associated disease … in-hospital infection control, appropriate antibiotic prescribing, and effective treatment of existing disease … Clostridium difficile-associated disease (CDAD) Nomination Summary Document http://effectivehealthcare.ahrq.gov

307. Diagnosis and Treatment of Clinical Alzheimer's-type Dementia (CATD) (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/catd-protocol-draft_0.pdf
     November 02, 2018 - Most individuals with dementia have Alzheimer’s disease (AD) as at least part of their underlying disease … ), or dementia due to a non-AD neurodegenerative disease. … Alzheimer's Disease. Centers for Disease Control and Prevention. … of Department of Health and Human Services Task Force on Alzheimer's Disease. … Pharmacological interventions for apathy in Alzheimer's disease.

308. Colon-Cancer-Gene-Profiling Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/colon-cancer-gene-profiling_research-protocol.pdf
     March 13, 2012 - diagnosed with stage II disease are between 58 and 83 percent. … will develop recurrence or die from their disease. … In this report, prognostic outcomes relate to disease prognosis, generally measured by rate of disease … o For disease-free survival, how was it determined? … Centers for Disease Control and Prevention Web site. Public Health Genomics.

309. Linking Dental Services to Treatment Outcomes for Diabetes: A Rapid Response Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/treatment-outcomes-diabetes-rapid-research.pdf
     November 01, 2024 - , including lower limb amputations, blindness, chronic kidney disease, and cardiovascular diseases.5 … , gingival infection, periodontal disease, and tooth loss.4 They are among the most common chronic diseases … and cardiovascular diseases, diabetes, and respiratory diseases: Summary of the consensus report … Periodontal Diseases and Cardiovascular Diseases, Diabetes, and Respiratory Diseases: Summary of the … Wrong study design Choi 2020 31882408 Impact of Treating Oral Disease on Preventing Vascular Diseases

310. Research White Paper Patient- or Participant-Generated Registries Addendum Registries for Evaluating Patient Outcomes Third Edition (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/patient-participant-generated-registries-guide-3rd-ed-addendum-white-paper.pdf
     February 01, 2018 - Evolution and Variation The phenomenon of individuals affected by diseases establishing registries … history of a disease. … able to help generate evidence to support the development of treatment guidelines, especially for diseases … into care coordination and practice guidelines has become a model for other diseases.19, 73-84 Planning … Methodology of clinical research in rare diseases: development of a research program in juvenile neuronal

311. Liver-Cancer-Therapy Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/liver-cancer-therapy_research-protocol.pdf
     November 28, 2012 - HCC is a highly lethal disease, and worldwide it is the fifth most common cancer and the third leading … Disease is staged from 0 to D. … Patients with chronic liver disease are classified as Child-Pugh class A, B, or C based upon the total … Another scoring system for chronic liver disease is the Model for End-Stage Liver Disease (MELD) score … In addition, the use of various disease classification systems and the inability to translate disease

312. High-Cholestorol-Medicines-Update Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medicines-update_executive.pdf
     February 01, 2014 - valve disease, congenital heart disease, and hypertension. … (CHD), cerebrovascular disease, and peripheral artery disease. … CHD = coronary heart disease; FDA = U.S. … without preexisting cardiovascular disease. … Reduced or modified dietary fat for preventing cardiovascular disease.

313. Psoriatic Arthritis Surveillance Assesment_CER 54_Low (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/arthritis-psoriatric_surveillance.pdf
     March 01, 2013 - Surveillance Report: March 2013 Key Findings: - Key Question 1: Conclusion regarding biologic Disease … Compared with placebo in one good systematic review study, sulfasalazine reduced disease activity. … factor-alpha antagonists and the risk of hospitalization for infection in patients with autoimmune diseases … INTERNAL MEDICINE BMJ JAMA LANCET NEW ENGLAND JOURNAL OF MEDICINE ANNALS OF THE RHEUMATIC DISEASES … Do Not Know KQ 1: For patients with PsA, do drug therapies differ in their ability to reduce disease

314. Ahrq Community Forum Webinar Branson (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/ahrq_community_forum_webinar_branson.pdf
     October 13, 2011 - SRA. 4 Characteristics of Patient Representatives • Have personal experience with the disease … • Are knowledgeable about treatment options and/or the science of the disease • Are able to be … groups may offer an opportunity to identify patients who might be underrepresented (such as for rare diseases … Advocacy experience – Ability to represent other patients/survivors – Knowledge and skills related to disease … area – Alternate disease experience – Work experience – Education • Interview representatives

315. Modeling to evaluate benefits and harms of new diagnostic tests compared to established diagnostic tests – uses and limitations (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/benefits-harms-modeling_research.pdf
     November 19, 2009 - from non-disease. … At that time, vidarabine was proven an effective yet toxic treatment for the disease, which has high … Exploring Hypothetical Conditions for Diseases With No Effective Treatment As mentioned before, a … The “disease” is then an arbitrary construct that may or may not correspond to different prognoses. … The MISCAN simulation program for the evaluation of screening for disease.

316. Since their introduction in 20xx, DES have been shown in clinical trials to decrease TLR (… (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/coronary-stents-outcomes_research.pdf
     January 01, 2010 - PCI procedure codes (International Classification of Diseases, Ninth Revision, Clinical Modification … 2 Vessel Disease 3 Vessel Disease 2004 PCI 2005 PCI 2006 PCI Overall .5 .6 .75 1 1.25 1.5 2 Death … 2 Vessel Disease 3 Vessel Disease 2004 PCI 2005 PCI 2006 PCI Overall .5 .6 .75 1 1.25 1.5 2 Myocardial … 2 Vessel Disease 3 Vessel Disease 2004 PCI 2005 PCI 2006 PCI Overall .5 .6 .75 1 1.25 1.5 2 Major … 2 Vessel Disease 3 Vessel Disease 2004 PCI 2005 PCI 2006 PCI Overall .5 .6 .75 1 1.25 1.5 2 Stroke

317. Automated-Entry Patient Generated Health Data for Chronic Conditions: The Evidence on Health Outcomes (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/patient-generated-health-data-protocol-chronic-conditions.pdf
     March 17, 2020 - assessed to determine efficacy related to health outcomes for consumers with (or at risk for) chronic diseases … obstructive pulmonary disease, or asthma. … Which specific chronic diseases do you think are most important for us to include? 3. … challenge to interpreting research and evaluation studies on consumer health technologies for chronic diseases … 'coronary artery disease'/exp OR (coronar*:ti AND arter*:ti AND (disease*:ti OR syndrome*:ti OR atheroscleros

318. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-2007_executive.pdf
     January 01, 2007 - affects 1 percent of the U.S. adult population (or upwards of 2 million individuals), is an autoimmune disease … The disease tends to affect the small joints of the hands and feet in a symmetric pattern, but other … PsA is associated with the skin disease psoriasis. … Available therapies for RA include corticosteroids; synthetic disease-modifying antirheumatic drugs, … However, all arms had similar disease activity by disease activity score (DAS) values at 2 years regardless

319. Coronary-Artery-Stenting Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/coronary-artery-stenting_executive.pdf
     February 01, 2013 - and intermediate coronary stenosis, excluding left main disease and acute MI. … IVUS or no IVUS groups, irrespective of variations in anatomic left main disease. … and intermediate coronary stenosis, excluding left main disease and acute MI. … and lower grade angina, and excluded patients with left main disease and acute MI … patients with left main disease.

320. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-kidney-disease-anemia-2011_research-protocol.pdf
     January 01, 2011 - no underlying kidney disease. … Bethesda, MD, National Institute of Diabetes and Digestive and Kidney Diseases; 2010. … Correction of anemia with epoetin alfa in chronic kidney disease. … Clinical aspects of iron use in the anemia of kidney disease. … hemodialysis.af. 41,409 62 peritoneal dialysis.mp. or exp Peritoneal Dialysis/ 23,533 63 exp Kidney Diseases